Home ›

Hematology

Anemia After Stroke Equals Bad News

3.8

Following a stroke, suffering from anemia could prove to be a fatal combination. Stroke survivors who suffer from anemia are nearly three times more likely to die the first year after a stroke.

Related Topics:

Tasigna Recommended for Second-Line CML

3.066665

Tasigna (nilotinib) is one of the three major medications currently being used to treat chronic myeloid leukemia (CML). Now it has become a preferred drug in one country.

Related Topics:

Cephalon, Inc. Issues Voluntary Nationwide Recall of Treanda

3.1

Cephalon, Inc. is voluntarily recalling Treanda® (bendamustine HCL) for Injection 25mg/8mL; lot TB30111, expiration date 12/2012. This product lot is being recalled due to the presence of particulate matter found in a single vial, which has been identified as glass fragments.

Related Topics:

FDA Approves Subcutaneous Administration of Takeda Drug Velcade

3.387095

The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for Velcade (bortezomib).

Related Topics:

Marathon Against CML Still Not Won

3.133335

Remarkable advancements have been made in the treatment of chronic myeloid leukemia. But the race has not yet been won, according to one of the nation's preeminent experts in the field.

Related Topics:

Salty Soul Singer Etta James Dies

3.375

You've probably heard her music, even if you don't recognize her name. "At Last" - the classic love song - is a wedding favorite. And you may know "The Wallflower," or "Something's Got a Hold on Me."

Related Topics:

Treatment Options for Chronic Myeloid Leukemia

3.112995

Chronic myeloid leukemia (CML) has a number of treatment options. And those options may be expanding in the near future. A drug still being investigated shows positive results in treating newly diagnosed CML patients.

Related Topics:

No Longer a Bitter Pill to Swallow

3.53846

Gleevec (imatinib) is among the most widely prescribed medications to treat chronic myeloid leukemia (CML) in both children and adults. Problem is, it's really hard for kids to swallow this oral medication, but that's about to change.

Related Topics:

FDA Drug Safety Communication: Adcetris (brentuximab vedotin)

0

The U.S. Food and Drug Administration (FDA) is notifying the public that two additional cases of progressive multifocal leukoencephalopathy (PML), a rare but serious brain infection that can result in death, have been reported with the lymphoma drug Adcetris (brentuximab vedotin).

Related Topics:

Does Chemotherapy Cause Cancer to Return?

3.636365

Most patients with acute myeloid leukemia will undergo chemotherapy to treat the disease. But this treatment may be causing harm as well as helping, according to a new study.

Related Topics:
Syndicate content